Skip to main content
CriticalFDAfda-F-0083-2023SALMONELLA CONTAMINATION

Fresh Salmon fillets packed in 10-50 lb. corrugated cardboard or Styrofoam boxes

⚠ Critical Alert — Stop Using Immediately

This product has been flagged with severe risks (Salmonella contamination). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.

Category
Units Affected
89,953
Recall Date
October 20, 2022
Issuing Agency
Hazard
Salmonella Contamination

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0083-2023.

Possible contamination with salmonella

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0083-2023.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Mariscos Bahia Inc or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0083-2023.

Mariscos Bahia Inc

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Mariscos Bahia Inc Recall FAQ

Mariscos Bahia Inc is the subject of a seafood safety report: Fresh Salmon fillets packed in 10-50 lb. corrugated cardboard or Styrofoam boxes. The notice was published on October 20, 2022 by the U.S. Food and Drug Administration (FDA). Approximately 89,953 units are potentially affected.